大麻素受体与内源性大麻素：新角色的证据
Cannabinoid receptors and endocannabinoids: evidence for new players.
作者信息
Mackie Ken, Stella Nephi
机构信息
Department of Anesthesiology, University of Washington, 1959 Pacific Ave N, Seattle, WA 98195-7280, USA.
出版信息
AAPS J. 2006 Apr 28;8(2):E298-306. doi: 10.1007/BF02854900.
Abstract
It is now well established that the psychoactive effects of Cannabis sativa are primarily mediated through neuronal CB1 receptors, while its therapeutic immune properties are primarily mediated through CB2 receptors. Two endocannabinoids, arachidonoylethanolamide and 2-arachidonoylglycerol, have been identified, their action on CB1 and CB2 thoroughly characterized, and their production and inactivation elucidated. However, many significant exceptions to these rules exist. Here we review the evidence suggesting that cannabinoids can modulate synaptic transmission, the cardiovascular system, and the immune system through receptors distinct from CB1 and CB2, and that an additional "independent" endocannabinoid signaling system that involves palmitoylethanolamide may exist.
摘要
现已明确，大麻的精神活性作用主要通过神经元CB1受体介导，而其治疗免疫特性主要通过CB2受体介导。两种内源性大麻素，花生四烯酸乙醇胺和2-花生四烯酸甘油已被鉴定出来，它们对CB1和CB2的作用已得到充分表征，其产生和失活机制也已阐明。然而，这些规则存在许多显著的例外情况。在这里，我们综述了相关证据，这些证据表明大麻素可以通过不同于CB1和CB2的受体调节突触传递、心血管系统和免疫系统，并且可能存在一个涉及棕榈酰乙醇胺的额外“独立”内源性大麻素信号系统。
相似文献
1
Cannabinoid receptors and endocannabinoids: evidence for new players.大麻素受体与内源性大麻素：新角色的证据
AAPS J. 2006 Apr 28;8(2):E298-306. doi: 10.1007/BF02854900.
2
An introduction to the endocannabinoid system: from the early to the latest concepts.内源性大麻素系统简介：从早期概念到最新概念
Best Pract Res Clin Endocrinol Metab. 2009 Feb;23(1):1-15. doi: 10.1016/j.beem.2008.10.013.
3
The endocannabinoid system: its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation.内源性大麻素系统：其一般作用策略、药理学调控工具及潜在治疗应用
Pharmacol Res. 2009 Aug;60(2):77-84. doi: 10.1016/j.phrs.2009.02.010. Epub 2009 Mar 4.
4
Endocannabinoid system: emerging role from neurodevelopment to neurodegeneration.内源性大麻素系统：从神经发育到神经退行性变的新作用
Mini Rev Med Chem. 2009 Apr;9(4):448-62. doi: 10.2174/138955709787847921.
5
The endocannabinoid-CB receptor system: Importance for development and in pediatric disease.内源性大麻素-CB受体系统：对发育及儿科疾病的重要性。
Neuro Endocrinol Lett. 2004 Feb-Apr;25(1-2):24-30.
6
Retrograde signalling by endocannabinoids.内源性大麻素的逆行信号传导。
Handb Exp Pharmacol. 2005(168):367-83. doi: 10.1007/3-540-26573-2_12.
7
The endocannabinoid system: physiology and pharmacology.内源性大麻素系统：生理学与药理学
Alcohol Alcohol. 2005 Jan-Feb;40(1):2-14. doi: 10.1093/alcalc/agh110. Epub 2004 Nov 18.
8
Cannabinoid physiology and pharmacology: 30 years of progress.大麻素生理学与药理学：30年的进展
Neuropharmacology. 2004;47 Suppl 1:345-58. doi: 10.1016/j.neuropharm.2004.07.030.
9
The pharmacology of cannabinoid receptors and their ligands: an overview.大麻素受体及其配体的药理学：概述
Int J Obes (Lond). 2006 Apr;30 Suppl 1:S13-8. doi: 10.1038/sj.ijo.0803272.
10
Cannabinoid receptor-dependent metabolism of 2-arachidonoylglycerol during aging.衰老过程中2-花生四烯酸甘油酯的大麻素受体依赖性代谢
Exp Gerontol. 2014 Jul;55:134-42. doi: 10.1016/j.exger.2014.04.008. Epub 2014 Apr 24.
引用本文的文献
1
Treatment of Migraine With Phytocannabinoids, the Involvement of Endocannabinoids in Migraine, and Potential Mechanisms of Action.植物大麻素治疗偏头痛、内源性大麻素在偏头痛中的作用及潜在作用机制
Pain Res Manag. 2025 Jul 1;2025:7181066. doi: 10.1155/prm/7181066. eCollection 2025.
2
Possible Combinatorial Utilization of Phytochemicals and Extracellular Vesicles for Wound Healing and Regeneration.植物化学物质与细胞外囊泡联合应用于创伤愈合与再生。
Int J Mol Sci. 2024 Sep 26;25(19):10353. doi: 10.3390/ijms251910353.
3
Les données probantes et les recommandations sur le cannabis à des fins médicales chez les enfants.关于儿童医用大麻的证据和建议。
Paediatr Child Health. 2024 Apr 5;29(2):104-121. doi: 10.1093/pch/pxad077. eCollection 2024 May.
4
Medical cannabis for children: Evidence and recommendations.儿童医用大麻：证据与建议。
Paediatr Child Health. 2024 Apr 5;29(2):104-121. doi: 10.1093/pch/pxad078. eCollection 2024 May.
5
Pharmacokinetic modelling of orally administered cannabidiol and implications for medication control in horses.口服大麻二酚的药代动力学建模及其对马匹药物控制的影响。
Front Vet Sci. 2023 Aug 9;10:1234551. doi: 10.3389/fvets.2023.1234551. eCollection 2023.
6
How do phytocannabinoids affect cardiovascular health? An update on the most common cardiovascular diseases.植物大麻素如何影响心血管健康？关于最常见心血管疾病的最新情况。
Ther Adv Chronic Dis. 2023 Jan 6;14:20406223221143239. doi: 10.1177/20406223221143239. eCollection 2023.
7
Anti-Microbial Activity of Phytocannabinoids and Endocannabinoids in the Light of Their Physiological and Pathophysiological Roles.从植物大麻素和内源性大麻素的生理及病理生理作用角度看其抗菌活性
Biomedicines. 2022 Mar 9;10(3):631. doi: 10.3390/biomedicines10030631.
8
Endocannabinoid System as a Promising Therapeutic Target in Inflammatory Bowel Disease - A Systematic Review.内源性大麻素系统作为炎症性肠病有前途的治疗靶点——系统评价。
Front Immunol. 2021 Dec 22;12:790803. doi: 10.3389/fimmu.2021.790803. eCollection 2021.
9
An Evaluation of Understudied Phytocannabinoids and Their Effects in Two Neuronal Models.评估两种神经细胞模型中研究较少的植物大麻素及其作用。
Molecules. 2021 Sep 2;26(17):5352. doi: 10.3390/molecules26175352.
10
Targeting the endocannabinoid system for management of HIV-associated neuropathic pain: A systematic review.靶向内源性大麻素系统治疗HIV相关神经性疼痛：一项系统评价。
IBRO Neurosci Rep. 2021 Jan 25;10:109-118. doi: 10.1016/j.ibneur.2021.01.004. eCollection 2021 Jun.
本文引用的文献
1
Species and strain differences in the expression of a novel glutamate-modulating cannabinoid receptor in the rodent hippocampus.啮齿动物海马体中一种新型谷氨酸调节大麻素受体表达的物种和品系差异。
Eur J Neurosci. 2005 Nov;22(9):2387-91. doi: 10.1111/j.1460-9568.2005.04401.x.
2
Identification and functional characterization of brainstem cannabinoid CB2 receptors.脑干大麻素CB2受体的鉴定与功能表征
Science. 2005 Oct 14;310(5746):329-32. doi: 10.1126/science.1115740.
3
Depolarization-induced suppression of excitation in murine autaptic hippocampal neurones.去极化诱导的小鼠海马自突触神经元兴奋抑制
J Physiol. 2005 Dec 1;569(Pt 2):501-17. doi: 10.1113/jphysiol.2005.091918. Epub 2005 Sep 22.
4
Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages.N-酰基乙醇胺水解酸酰胺酶参与巨噬细胞中花生四烯酸乙醇胺及其他N-酰基乙醇胺的降解。
Biochim Biophys Acta. 2005 Oct 1;1736(3):211-20. doi: 10.1016/j.bbalip.2005.08.010. Epub 2005 Aug 29.
5
The challenge of brain lipidomics.脑脂质组学的挑战。
Prostaglandins Other Lipid Mediat. 2005 Sep;77(1-4):23-34. doi: 10.1016/j.prostaglandins.2004.09.006.
6
Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli.小胶质细胞中大麻素CB2受体对炎症刺激的响应调节。
J Neurochem. 2005 Oct;95(2):437-45. doi: 10.1111/j.1471-4159.2005.03380.x. Epub 2005 Aug 8.
7
The endocannabinoid system drives neural progenitor proliferation.内源性大麻素系统驱动神经祖细胞增殖。
FASEB J. 2005 Oct;19(12):1704-6. doi: 10.1096/fj.05-3995fje. Epub 2005 Jul 21.
8
Synaptically driven endocannabinoid release requires Ca2+-assisted metabotropic glutamate receptor subtype 1 to phospholipase Cbeta4 signaling cascade in the cerebellum.在小脑中，突触驱动的内源性大麻素释放需要Ca2+辅助的代谢型谷氨酸受体1型至磷脂酶Cβ4信号级联反应。
J Neurosci. 2005 Jul 20;25(29):6826-35. doi: 10.1523/JNEUROSCI.0945-05.2005.
9
A second N-acylethanolamine hydrolase in mammalian tissues.哺乳动物组织中的第二种N-酰基乙醇胺水解酶。
Neuropharmacology. 2005 Jun;48(8):1079-85. doi: 10.1016/j.neuropharm.2004.12.017.
10
Evidence for novel cannabinoid receptors.新型大麻素受体的证据。
Pharmacol Ther. 2005 May;106(2):133-45. doi: 10.1016/j.pharmthera.2004.11.005. Epub 2005 Jan 11.
Zotero 插件